AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Bls Pharmaceuticals Limited

0.985

+0.0303.14%

Volume:355.02K

Turnover:339.60K

Market Cap:226.53M

PE:14.70

High:0.990

Open:0.955

Low:0.940

Close:0.955

52wk High:1.295

52wk Low:0.760

Shares:229.98M

Float Shares:- -

Volume Ratio:2.27

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.067

EPS(LYR):0.067

ROE:71.30%

ROA:34.10%

PB:7.29

PE(LYR):14.70

Loading ...

Overview Company News Filings

Bls Pharmaceuticals Ltd-Angus Walker Appointed Alternate Director to Edward Myer

THOMSON REUTERS

AI was supposed to destroy jobs. It’s doing the opposite

The West Australian

Australia's BLS Pharmaceuticals Extends Gains on Upbeat Outlook, Strong Results

BLS Pharmaceuticals Sees FY27 Adjusted. Ebitda Margin 23% - 26%

BLS Pharmaceuticals Posts FY Net Profit After Tax of A$15.4 MLN

Bls Pharmaceuticals - no Dividends Have Been Paid or are Proposed

THOMSON REUTERS

Bls Pharmaceuticals - FY Revenue A$74.2 Million

THOMSON REUTERS

BLS Pharmaceuticals Reports Record Revenue in June Quarter; Fiscal 2026 Revenue Hits Top End of Guidance Range

MT Newswires Live

Australia's BLS Pharmaceutical Soars on Strong Full-year Results

BLS Pharmaceuticals Posts FY26 Adjusted Ebitda of A$19 MLN

Bls Pharmaceuticals - Reports Qtrly Revenue of A$22.5 Mln

THOMSON REUTERS

Australia's BLS Pharmaceuticals Gains on Agreement to Commercialise Trexapharm

Bls Pharmaceuticals Ltd-agreement with Trexapharm for Commercialisation of Trexavive

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/BLS.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BLS.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BLS.AU\",,,,,undefined,":{"symbol":"BLS.AU","market":"AU","secType":"STK","nameCN":"Bls Pharmaceuticals Limited","latestPrice":0.985,"timestamp":1791436320000,"preClose":0.955,"halted":0,"volume":355017,"delay":0,"changeRate":0.03141361256544505,"nameEN":"Bls Pharmaceuticals Limited","floatShares":0,"shares":229978083,"eps":0.066999,"marketStatus":"Not Yet Opened","change":0.03,"latestTime":"10-08 16:12:00 AEDT","open":0.955,"high":0.99,"low":0.94,"amount":339596,"amplitude":0.052356,"askPrice":1.01,"askSize":10825,"bidPrice":0.94,"bidSize":39706,"shortable":3,"etf":0,"ttmEps":0.066999,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1791500400000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.955,"openAndCloseTimeList":[[1791414000000,1791435600000]],"volumeRatio":2.269045,"lotSize":0,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BLS.AU","preClose":0.955,"auctionPrice":0.985,"auctionVolume":11578,"auction":3,"marketStatus":"盘后竞价","timestamp":1791436202976}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BLS.AU\",,,,,undefined,":{"symbol":"BLS.AU","floatShares":0,"roa":"34.10%","roe":"71.30%","lyrEps":0.066999,"volumeRatio":2.269045,"shares":229978083,"dividePrice":0,"high":0.99,"amplitude":0.052356,"preClose":0.955,"low":0.94,"week52Low":0.76,"pbRate":"7.29","psRate":"3.06","week52High":1.295,"institutionHeld":0,"latestPrice":0.985,"committee":0.57155,"eps":0.066999,"divideRate":0,"volume":355017,"delay":0,"ttmEps":0.066999,"open":0.955,"prevYearClose":0.955,"prevWeekClose":1.02,"prevMonthClose":1.05,"prevQuarterClose":1.05,"fiveDayClose":1.02,"twentyDayClose":1.18,"sixtyDayClose":0.93},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BLS.AU\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"BLS.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788134400000,"name":null,"time":"","dateTimestamp":1788098400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BLS.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BLS.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667334126","title":"Bls Pharmaceuticals Ltd-Angus Walker Appointed Alternate Director to Edward Myer","url":"https://stock-news.laohu8.com/highlight/detail?id=2667334126","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667334126?lang=en_us&edition=fundamental","pubTime":"2026-09-14 06:25","pubTimestamp":1789338309,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260913:nTUEC80D0D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665499233","title":"AI was supposed to destroy jobs. It’s doing the opposite","url":"https://stock-news.laohu8.com/highlight/detail?id=2665499233","media":"The West Australian","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665499233?lang=en_us&edition=fundamental","pubTime":"2026-09-08 02:32","pubTimestamp":1788805972,"startTime":"0","endTime":"0","summary":"THE ECONOMIST: The AI boom is creating employment opportunities faster than it destroys them","market":"us","thumbnail":"https://images.thewest.com.au/publication/C-22838616/cbe9bab8d78ae9ab00583bb935719644468f21bf.jpg","type":0,"news_type":0,"thumbnails":["https://images.thewest.com.au/publication/C-22838616/cbe9bab8d78ae9ab00583bb935719644468f21bf.jpg"],"rights":{"source":"thewest_stock","url":"https://thewest.com.au/business/the-economist/the-economist-the-jobs-apocalypse-is-postponed-an-ai-jobs-boom-is-here-c-22838616","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://thewest.com.au/business/the-economist/the-economist-the-jobs-apocalypse-is-postponed-an-ai-jobs-boom-is-here-c-22838616","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"thewest_stock","symbols":["BK7048","BLS.AU","CHAT","QTOC","VGT","AGIX","ARTY","AIPO","BK4588","BK4585","VTHR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664887723","title":"Australia's BLS Pharmaceuticals Extends Gains on Upbeat Outlook, Strong Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2664887723","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664887723?lang=en_us&edition=fundamental","pubTime":"2026-09-01 11:25","pubTimestamp":1788233110,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's BLS Pharmaceuticals extends gains on upbeat outlook, strong results** Shares of Australia's BLS PharmaceuticalsBLS.AXrise as much as 13.2% to A$1.200, hittingtheirhighest level since ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nL4N44T07C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663078746","title":"BLS Pharmaceuticals Sees FY27 Adjusted. Ebitda Margin 23% - 26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663078746","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663078746?lang=en_us&edition=fundamental","pubTime":"2026-08-31 15:50","pubTimestamp":1788162639,"startTime":"0","endTime":"0","summary":"BRIEF-BLS Pharmaceuticals Sees FY27 Adjusted. EBITDA Margin 23% - 26%Aug 31 (Reuters)-BLS Pharmaceuticals LtdBLS.AX:SEES FY27 ADJUSTED. EBITDA MARGIN 23% - 26%SEES FY27 REVENUE A$105M – A$115MFurther company coverage:BLS.AX","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R03G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663902933","title":"BLS Pharmaceuticals Posts FY Net Profit After Tax of A$15.4 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2663902933","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663902933?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:41","pubTimestamp":1788144097,"startTime":"0","endTime":"0","summary":"BRIEF-BLS Pharmaceuticals Posts FY Net Profit After Tax Of A$15.4 MLNAug 31 (Reuters)-BLS Pharmaceuticals LtdBLS.AX:FY REVENUE A$74.2 MILLIONFY NET PROFIT AFTER TAX OF A$15.4 MILLIONNO DIVIDENDS HAVE BEEN PAID OR ARE PROPOSEDFurther company coverage:BLS.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663298400","title":"Bls Pharmaceuticals - no Dividends Have Been Paid or are Proposed","url":"https://stock-news.laohu8.com/highlight/detail?id=2663298400","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663298400?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:39","pubTimestamp":1788143995,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663029828","title":"Bls Pharmaceuticals - FY Revenue A$74.2 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2663029828","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663029828?lang=en_us&edition=fundamental","pubTime":"2026-08-31 10:39","pubTimestamp":1788143946,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nFWN44R00O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654409602","title":"BLS Pharmaceuticals Reports Record Revenue in June Quarter; Fiscal 2026 Revenue Hits Top End of Guidance Range","url":"https://stock-news.laohu8.com/highlight/detail?id=2654409602","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654409602?lang=en_us&edition=fundamental","pubTime":"2026-07-27 11:40","pubTimestamp":1785123634,"startTime":"0","endTime":"0","summary":"BLS Pharmaceuticals  reported record quarterly revenue of AU$22.5 million for the three months through June, up 5% from the previous quarter, according to a Monday filing with the Australian bourse.The quarterly sales brought fiscal 2026 revenue to about AU$75 million, 156% above the previous fiscal year and hitting the top end of the company's guidance range, per the filing.The company further reported record fiscal 2026 adjusted earnings before interest, taxes, depreciation, and amortization of AU$19 million, an increase of 190% from the prior year and also at the top end of its guidance range.Additionally, BLS Pharmaceuticals increased its cash balance to AU$13.3 million at the close of June from AU$8.5 million as of March 31.The company's shares gained over 1% in recent Monday trade.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654965920","title":"Australia's BLS Pharmaceutical Soars on Strong Full-year Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2654965920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654965920?lang=en_us&edition=fundamental","pubTime":"2026-07-27 11:05","pubTimestamp":1785121526,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's BLS Pharmaceutical soars on strongfull-year results** Shares of BLS PharmaceuticalBLS.AXrise as much as 7.1% to A$0.9, set to mark their steepest intraday pct rise since July 13, if t","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nL6N43T06F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654093251","title":"BLS Pharmaceuticals Posts FY26 Adjusted Ebitda of A$19 MLN","url":"https://stock-news.laohu8.com/highlight/detail?id=2654093251","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654093251?lang=en_us&edition=fundamental","pubTime":"2026-07-27 09:45","pubTimestamp":1785116758,"startTime":"0","endTime":"0","summary":"BRIEF-BLS Pharmaceuticals Posts FY26 Adjusted EBITDA Of A$19 MLNJuly 27 (Reuters)-BLS Pharmaceuticals LtdBLS.AX:REPORTS QTRLY REVENUE OF A$22.5 MILLIONREPORTS FY26 ADJUSTED EBITDA OF A$19 MILLION AT TOP END OF GUIDANCEFurther company coverage:BLS.AX","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43R0E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654067443","title":"Bls Pharmaceuticals - Reports Qtrly Revenue of A$22.5 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2654067443","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654067443?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:53","pubTimestamp":1785106406,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nFWN43R0E9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653731346","title":"Australia's BLS Pharmaceuticals Gains on Agreement to Commercialise Trexapharm","url":"https://stock-news.laohu8.com/highlight/detail?id=2653731346","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653731346?lang=en_us&edition=fundamental","pubTime":"2026-07-22 13:56","pubTimestamp":1784699810,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's BLS Pharmaceuticals gains on agreement to commercialise Trexapharm** Shares of BLS PharmaceuticalsBLS.AXrise 3.6% to A$0.87, headed for their best session since July 13, if trends hol","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260722:nL4N43O0EQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7048","BLS.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653789598","title":"Bls Pharmaceuticals Ltd-agreement with Trexapharm for Commercialisation of Trexavive","url":"https://stock-news.laohu8.com/highlight/detail?id=2653789598","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653789598?lang=en_us&edition=fundamental","pubTime":"2026-07-22 06:34","pubTimestamp":1784673267,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260721:nTUE3C7LWD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BLS.AU","BK7048"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":13,"code":"91000000","status":"200"}]}}